Ecolla™ PLLA
Ecolla™ PLLA by JETEMA stands as a robust collagen stimulator offering gradual, natural volumization lasting up to 24 months. Its key strengths include well-engineered microparticles, safe degradable composition, and a clinically backed mechanism. Bolstered by JETEMA's strong global educational outreach and scientific engagement, Ecolla offers practitioners confidence in delivering long-term, regenerative aesthetic outcomes.
Ecolla™ PLLA
Ecolla™ PLLA is JETEMA’s CE approved poly L lactic acid (PLLA) collagen stimulator, supplied as a 365 mg vial containing 150 mg PLLA, plus biocompatible excipients like carboxymethylcellulose and mannitol. It is intended for deep dermal to subcutaneous injection, typically administered in 3 sessions at 4–6 week intervals, offering gradual volumization and collagen induction for up to 24 months.
Key Features:
• Biodegradable PLLA (150 mg per vial) that stimulates slow, natural collagen production.
• Even, regular particles (20–63 µm) ensuring smooth flow, controlled deposition, and consistent results.
• CE approved medical device formulated with safe excipients (CMC, mannitol), free from toxic solvents.
• Long-lasting volume restoration, with clinical volumetric benefits lasting 24 months.
• Eco-safe profile: PLLA degrades via hydrolysis into water and carbon dioxide over 9–24 months.
About JETEMA Co., Ltd
JETEMA Co., Ltd., based in Seongnam si, South Korea, specializes in HA fillers, PLLA fillers, skin boosters, medical devices, and ODM/OEM aesthetic solutions. With a focus on research and education, including its ongoing Jetema Academic Meeting (JAM) series—and participation in global congresses like ASLS Tokyo, JETEMA has built a strong presence across 70+ countries.